Pages that link to "Q39814053"
Jump to navigation
Jump to search
The following pages link to Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia (Q39814053):
Displaying 50 items.
- New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia (Q26749177) (← links)
- B-acute lymphoblastic leukemia/lymphoblastic lymphoma (Q26798093) (← links)
- Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies (Q26828511) (← links)
- Genomic profiling of B-progenitor acute lymphoblastic leukemia (Q26829976) (← links)
- Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine (Q26864460) (← links)
- Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia (Q27851831) (← links)
- Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia (Q28390558) (← links)
- Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients (Q33573735) (← links)
- Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia (Q33590468) (← links)
- The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution (Q34167952) (← links)
- A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL (Q34217173) (← links)
- IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia (Q34358106) (← links)
- BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia. (Q34358853) (← links)
- Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation (Q35799360) (← links)
- Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia (Q35827910) (← links)
- Ikaros6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemia. (Q35958876) (← links)
- Minimal Residual Disease in AML: Why Has It Lagged Behind Pediatric ALL? (Q35992927) (← links)
- CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol (Q36115668) (← links)
- Alternative Splice Variants Modulates Dominant-Negative Function of Helios in T-Cell Leukemia (Q36147014) (← links)
- Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia (Q36562871) (← links)
- Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic (Q36752634) (← links)
- IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol (Q36862420) (← links)
- Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. (Q36862511) (← links)
- Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features (Q36967133) (← links)
- IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan (Q36977450) (← links)
- What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? (Q37060647) (← links)
- Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. (Q37226741) (← links)
- Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments (Q38005040) (← links)
- Ikaros and leukaemia (Q38371003) (← links)
- Genomics in acute lymphoblastic leukaemia: insights and treatment implications (Q38381463) (← links)
- Machine learning applications for prediction of relapse in childhood acute lymphoblastic leukemia. (Q38636061) (← links)
- Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome. (Q38716763) (← links)
- Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat It. (Q38756821) (← links)
- Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients (Q38841153) (← links)
- Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). (Q38974705) (← links)
- Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases (Q39657505) (← links)
- Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia (Q39674477) (← links)
- IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan (Q39730823) (← links)
- Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia (Q41090525) (← links)
- Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. (Q41556401) (← links)
- IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. (Q41688725) (← links)
- Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL. (Q41697696) (← links)
- Ikaros: master of hematopoiesis, agent of leukemia (Q42057738) (← links)
- Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia (Q42368324) (← links)
- Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletion (Q43201113) (← links)
- Microarray‐based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia (Q43488736) (← links)
- Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia (Q43817166) (← links)
- An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. (Q43922213) (← links)
- Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. (Q46933149) (← links)
- A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children. (Q47203054) (← links)